Plain-English translation of NCT06091254 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new experimental medication called to see if it can help people with follicular lymphoma—a slow-growing type of blood cancer—better than the current standard treatment. The study compares to the combination of (an older drug) plus chemotherapy, which is what doctors typically use right now. The trial will measure how well each treatment works, how safe it is, and how it affects quality of life.
Follicular lymphoma can be serious, and while current treatments help many people, doctors are looking for options that might work better or cause fewer side effects. This trial exists to see if this new medication could be a better choice for patients who are newly diagnosed and haven't received treatment yet.
You likely qualify if…
You likely don't qualify if…
The trial has two parts. First, all participants receive the new medication alone to make sure it is safe. Then, participants are randomly assigned to either continue the new medication or receive plus chemotherapy, followed by maintenance treatment to help keep the cancer under control. Throughout the trial, you will have regular visits to your doctor for blood tests, scans, and check-ups to see how you're doing and measure how well your treatment is working.
AI-generated summary from trial data · Aug 25, 2026 · Not medical advice
United States